Lexington Drug Co. Cubist Bought By Merck

The drug giant Merck is making another big acquisition in Massachusetts. It’s buying Cubist Pharmaceuticals in Lexington for $9.5 billion. It’s a sign drug companies are realizing the growing need for new antibiotics to fight so-called "superbugs."